Price $8.51 |
Market Cap
365.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.3
|
P/S
5.81
|
Dividend %
-
|
|
P/CF
6.0
|
P/FCF
-
|
Op. Cash Flow
-94.4K
|
FCF
-3.1
|
|
Op. Margin
-52.30%
|
Net Margin
-47.70%
|
ROE
-19.00%
|
ROI
-11.50%
|
|
ROA
-9.70%
|
EPS Growth
-427.60%
|
Current Ratio
4.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $9.48 | - | - | 1.41B | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $14.86 | - | - | 44.2M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 12M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
